Cancer remains one of the most pressing public health challenges worldwide, affecting millions of lives and compounding economic burdens along the way. Â .
The global cell therapy manufacturing market is on the brink of substantial expansion, with a projected value of US$ 4,134.48 million in 2023. This dynamic market is expected to sustain an impressive compound annual growth rate (CAGR) of 14.2% from 2023 to 2033, ultimately culminating in an estimated worth of around.
Cell Therapy Manufacturing Market En Route to US$ 13.9 Billion in 2032, Propelled by a Solid 14.2% C pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
AusBiotech Launches Industry-Led Strategy to Develop Australia as APAC Hub for Cell and Gene Manufacturing miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
As per Future Market Insights’ latest industry analysis, the valuation of the global cell therapy manufacturing market was around US$ 3.3 Bn in 2021, and is projected to exhibit a CAGR of close to 14.2% over the forecast period. The market is expected to reach US$ 13.9 Bn in 2032.Cell therapies are utilized widely t.